Heterogeneity in Adverse Event Assessment Between Countries Participating in an International Collaboration of Registries of Rheumatoid Arthritis Patients Using Janus Kinase Inhibitors (the Jak-pot Study)

Epidemiology Registry Working Grp

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)256-257
Number of pages3
JournalAnnals of the rheumatic diseases
Publication statusPublished - Jun 2021

Cite this